text new page (beta)
English (pdf)
Article in xml format
Article references
Curriculum ScienTI
Automatic translation
Cited by SciELO 
Cited by Google 
Similars in
SciELO 
Similars in Google 
uBio 
Permalink
Introduction
Canine visceral leishmaniasis (CVL), also known as “kala-azar,” is an infection caused by protozoa that are transmitted to animals and humans through the bite of an insect vector (DIETZE; CARVALHO, 2003). The etiological agent is an intracellular parasite of the genusLeishmania and the complex Leishmania (Leishmania) donovani that is known in the Americas as L. chagasiand transmitted by the phlebotomine Lutzomyia longipalpis (LUTZ; NEIVA, 1912; SANTOS, et al., 1998). In northern and northeastern Brazil, the vector is found in the forests and is part of the primary transmission cycle for the illness. L. longipalpis can adapt to various environments, and its population density is greater inside and around human habitations, which promotes disease transmission (BARATA et al., 2005). Other species including ducks, rodents, passerines, and chickens are considered risk factors for CVL transmission in these regions (BORGES et al., 2009).
The main clinical symptoms of CVL are as follows: development of skin lesions; periocular alopecia; nasal and/or auricular ulcers; fever; weight loss; lymphadenopathy; epistaxis; onychogryphosis; splenomegaly; conjunctivitis; emaciation; signs of renal failure, such as polyuria, polydipsia, and vomiting; neuralgia; polyarthritis; polymyositis; osteolytic lesions; and proliferative periostitis (MONTEIRO et al., 2009). Clinical diagnosis of CVL is difficult due to the myriad clinical symptoms that may be exhibited by apparently healthy animals, oligosymptomatic animals, and animals at advanced disease stages (GONTIJO; MELO, 2004). Various diagnostic assays are available, but they vary in sensitivity as a function of the clinical condition, parasite density, biological material, and the diagnostic methods used for analysis (BISUGO et al., 2007). The tests most commonly used to diagnose human visceral leishmaniasis (HVL) and CVL in Brazil are the indirect immunofluorescence assay (IIFA) and the enzyme-linked-immunosorbent assay (ELISA).
ELISA is considered a screening method for CVL diagnosis because it is rapid and can be automated for high throughput. Additionally, ELISA has 71% to 100% sensitivity and 85% to 100% specificity (ALVES; BEVILACQUA, 2004); the antigen (crude or recombinant) and protocol used can affect these rates. The use of crude or total antigen limits the specificity of ELISA and produces cross reactivity with other trypanosomatids or even phylogenetically distant organisms (PEDROSO, 2010).
IIFA is the test of choice for epidemiological surveys because it offers multiple advantages including low cost, high speed, and ease of use (ALVES; BEVILACQUA, 2004). IIFA results are expressed as titers and are considered positive starting at 1:40. The sensitivity of IIFA ranges from 68% to 100%, with 74% to 100% specificity. Similar to ELISA, IIFA produces cross-reactivity with samples from hosts infected by T. cruzi because of the phylogenetic proximity between the parasites (ALVES; BEVILACQUA, 2004; GONTIJO; MELO, 2004; ASSIS,2010). Antigens derived from promastigote forms may feature antigenic epitopes that are shared with other species of the family Trypanosomatidae, especially T. cruzi (SUNDAR; RAI, 2002). Such cross-reactions can be minimized by using purified or recombinant antigens. Purified antigens have shown better sensitivity than crude antigens, but preparation of the former is much slower and may require more sophisticated purification methods. Several recombinant antigens are already available for diagnosing HVL and CVL (GONTIJO; MELO, 2004). Thus, a requirement exists for confirmatory LV tests, such as parasitology methods and PCR. Although the parasitological method is specific, it has the disadvantages of being difficult to use in epidemiological surveys and being more invasive because puncture of the bone marrow or lymph node is required. Moreover, the method is less sensitive, yielding approximately 60% sensitivity for bone marrow smears and 30% sensitivity for lymph node smears. PCR is becoming increasingly useful for diagnosing VL because this technique more accurately detects the seronegative population and has almost completely overcome the limitations of serological techniques by providing faster speeds with greater specificity and sensitivity, even in asymptomatic patients (FEITOSA et al., 2000). The limitations on using PCR for epidemiological surveys are the cost, availability of reagents and equipment, and poor field adaptability (ALVES; BEVILACQUA, 2004). Thus, whenever using serological diagnosis for CVL, it is important to perform a differential diagnosis that includes Chagas disease (CD) while remaining attentive to the clinical signs exhibited by the animal, if present, and epidemiological aspects, including the point of origin (whether the area is endemic for leishmaniasis or CD), presence of vectors (phlebotomine for leishmaniasis and triatomine for CD), and contact between the dog and wild animals, which are major reservoirs of both Leishmania spp. and T. cruzi (LUCIANO et al., 2009).
CD, or American trypanosomiasis, is a zoonotic disease resulting from infection by the protozoan T. cruzi, which is transmitted by a hematophagous insect of the genus Triatoma that is commonly known as the “barber bug” or “kissing bug” and inhabits cracks in clay or wooden walls (REY, 2008). CD is endemic to various Latin American countries and is transmitted through vectors, blood transfusions, consuming contaminated foods, breast-feeding, or the transplacental route (REY, 2008).
Wild and domestic animals, including dogs, are major reservoirs of CD and can promote disease transmission (COHEN; GURTLER, 2001). Diagnosis of CD also relies on the use of serological assays such as IIFA, ELISA, and the hemagglutination inhibition (HAI) assay. More complex tests such as PCR and the western blot (WB) can be used for confirmation of both the acute and chronic forms of CD (GOMES, 2004; PINTO, 2009).
A study conducted by Correa (2010)from 2008 to 2010 in the Cardiology Outpatient Clinic of Araguaína – TO found a prevalence of 9.5% for CD in human patients, confirming the presence of the etiological agent for CD in the municipality under study. Thus, canine infection byT. cruzi at the investigated location is possible. The potential for CVL false-positives should be considered because they may lead to erroneous diagnoses and improper recommendations for euthanasia of the specified dogs.
Because Araguaína – TO has been designated a priority municipality for monitoring and control of visceral leishmaniasis (VL) in Brazil, according to the average number of cases from 2008 to 2010 (BRASIL, 2010), and because there are confirmed human cases of CD demonstrating the presence of the etiological agent in the region, the purpose of the present study was to test for serological cross-reactivity between antigens for L. chagasi and T. cruzi, which could yield false positives for CVL in sero-epidemiological surveys. An additional aim was to investigate the status of CD among the canine population in Araguaína – TO.
Materials and Methods
1.Serum sampling
IgG antibodies against L. chagasi and againstT. cruzi were studied in serum samples from 111 dogs from the municipality of Araguaína – Tocantins, which is endemic for CVL and CD. All of the samples were provided by the Center for Control of Zoonotic Diseases of the municipality of Araguaína – TO and initially analyzed by IIFA at the Central Laboratory (Laboratório Central – LACEN) of Araguaína – TO. The same samples were subsequently sent to the Protozoology Laboratory at the São Paulo Institute for Tropical Medicine of the University of São Paulo (Universidade de São Paulo – USP), which is a reference center for CD diagnosis, and were subjected to ELISA for the detection of anti-Leishmania antibodies, followed by a TESA-blot for the detection of anti-T. cruziantibodies.
2.Serological tests
2.1IIFA
IIFA was performed at LACEN in Araguaína – TO using a commercial kit (Biomanguinhos®) according to the manufacturer's instructions.
2.2ELISA
ELISA was performed in the Protozoology Laboratory at the São Paulo Institute for Tropical Medicine – USP. Promastigotes of L. chagasi, strain MHOM/BR/1972/LD, were obtained from cultures in liquid RPMI medium containing 10% fetal serum. The parasites were concentrated by centrifugation at 2,500 rpm for 10 minutes, and the suspensions obtained were immediately frozen and stored at -80°C. To prepare the soluble antigen, promastigotes were suspended in 10 volumes of lysis buffer (0.05 M TRIS-HCL, pH 6.0; 4 M Urea; 5 mM EDTA; 0.5 mM PMSF; 0.1 M KCL; and 0.5% SDS), heated to 65 °C for 15 minutes, and centrifuged at 10,000 rpm. The protein concentration of the soluble antigen was measured from the supernatant by the Bradford method, and the prepared antigen was aliquoted and stored at –80 °C. Highbinding polystyrene Costar plates (Corning, USA) were used for the ELISA. The plates were sensitized with 10 mg/mL of L. chagasi (50 mL/well) diluted in 0.05 M carbonate-bicarbonate buffer (pH 9.6). After blocking with 5% skim milk (Molico, Nestlé), 50 mL of serum (1:200) were added to the plates. After being incubated and washed, the plates received 50 mL of peroxidase-conjugated dog anti-IgG (Sigma Co, EUA). The antigen-antibody complex was visualized by addition of a chromogenic substrate (5 mg ortho-phenylenediamine – OPD; 7.5 mL 30% hydrogen peroxide – H2O2; 12 mL 0.05 M citrate-citric acid buffer, pH 5.0) and interrupted by the addition of 25 mL 4 N HCL. The optical density was obtained on an ELISA reader (Multiskan-Titertek II) at 492 nm.
2.3TESA-blot
TESA-blotting was performed at the São Paulo Institute for Tropical Medicine (IMTSP) – USP following a published protocol (UMEZAWA et al., 1996, 2001). The TESA protein components were separated by SDS-PAGE (TOWBIN et al., 1979) in a 7% gel, and the proteins were transferred to a 0.45 mm nitrocellulose (NTC) membrane. After blocking the NTC membrane with 5% skim milk, the membrane containing the antigen was cut into 5- mm strips that were incubated with dog sera (1:100). The complex was formed by adding peroxidase-conjugated dog anti-IgG (Sigma Co, EUA) and visualized by adding a developing solution (6 mg 4-chloronaphthol, 2 mL methanol, 10 mL PBS, and 10 µL H2O2). After bands appeared, the reaction was stopped by adding distilled water and recorded by digital photo documentation. The following proteins were used as molecular weight standards (Sigma Co, USA): carbonic anhydrase (29 kDa), egg albumin (45 kDa), bovine albumin (66 kDa), phosphorylase B (97 kDa), galactosidase (116 kDa), and myosin (205 kDa).
Results
The positive detection rate for anti-L. chagasi IgG antibodies by IIFA (LACEN-Araguaína) was 54.95% (61/111) and 51.35% (57/111) by ELISA (IMTSP-USP) (Figure 1). Figure 1 shows that 14.8% (9/61) of samples that were positive by IIFA-LACEN were negative by ELISA-São Paulo, and 10% (5/50) of samples that were negative by IIFA were positive by ELISA. The inter-assay Kappa coefficient of agreement was 0.74. Table 1lists differences in the results obtained by both of the methods applied.
Figure 1. ELISA results for analysis of anti-L. chagasi IgG antibodies in dogs from Araguaína – TO that were positive and negative by IIFA. The shaded area represents samples considered non-reactive.
Table 1. Comparison of the results from L. chagasi IIFA performed in Araguaína and ELISA performed in São Paulo.
| IIFA-Araguaína | ELISA-São Paulo | Total | |
|---|---|---|---|
| Positive | Negative | ||
| Positive | 52 | 9 | 61 |
| Negative | 5 | 45 | 50 |
| Total | 57 | 54 | 111 |
Study of the anti-T. cruzi IgG antibodies revealed that 4.5% (5/111) of the samples were positive by TESA-blot (Figure 2). Four out of the five dogs suspected of infection byT. cruzi were also positive by ELISA for diagnosis of leishmaniasis, while three of the canines were negative by IIFA (Figure 1). Only one animal was considered co-infected with Leishmania spp. The reactivity profile of these samples by TESA-blot was quantitatively lower than the reactivity of dogs known to have CD (Figure 2, row 6).
Discussion
VL is a chronic disease that is fatal in both humans and dogs. The clinical diagnosis is complex and should be performed using a combination of serological, parasitological, and/or molecular tests (SILVA, 2007). According to a study conducted by Bevilacqua et al. (2001), CVL precedes human cases because the spatial and chronological distribution of canine cases in the city of Belo Horizonte – MG has occurred much earlier than reports of human cases. Therefore, dogs are considered the main reservoir of the disease for humans. This finding highlights the importance of CVL in Araguaína due to the high regional prevalence of dogs seropositive for L. chagasi. Of the 5,183 canine samples analyzed in 2010, 2,544 (49.08%) were diagnosed as positive for CVL by IIFA (LACEN/TO, 2010).
VL and CD are serious public health problems in endemic and epidemic areas where these diseases coexist due to individual and environmental risk factors such as mass migration, urbanization, and deforestation. In addition, dogs are a domestic reservoir for both diseases (BRASIL, 2006; RIBEIRO, 2010). The high rate of positivity for CVL (51.35%) found by ELISA in the present study was much higher than the rates of 30.67% and 37.3% reported in Dourados – MS (MARCONDES, 2009) and Cuiabá – MT (ALMEIDA et al., 2010), respectively. This finding stresses the importance of accurate disease diagnosis because cross-reactivity is possible.
TESA-blotting was used to study anti-T. cruziantibodies. This assay consists of a WB prepared using exoantigens from trypomastigotes of T. cruzi strain Y, which is considered positive when a 150-kDa band appears. This method has 100% sensitivity and specificity, does not suffer cross-reactivity, permits differentiation between the acute and chronic phases of CD, and is considered a confirmatory test when conventional serological results are inconclusive (UMEZAWA et al., 1996; NAKAZAWA et al., 2001; SILVA, 2007). In the present study, anti-T. cruzi antibodies were found in 4.5% (5/111) of the analyzed canine serum samples. Although lower than the 10.7% rate reported by Souza (2007) in Mato Grosso do Sul, the rate reported herein indicated the presence of dogs with CD in the region endemic for CVL. It should be noted that four of the samples positive for CD by TESA-blot were reactive on ELISA, and three were non-reactive by IIFA. This finding demonstrates the lack of cross-reactivity between L. chagasi and T. cruzi by IIFA. Similar findings were reported by Rosypal et al. (2007), who analyzed dog sera from Colombia (n=258) and São Paulo (n=107) and found no positivity for T. cruzi by IIFA among samples that were seropositive for L. chagasi. In the present study, only one dog exhibited reactivity on the applied assays and was considered co-infected by both diseases. This finding suggests the involvement of that dog in the epidemiology of CD in Araguaína.
The results obtained in the present study suggest that dogs diagnosed as seroreactive for L. chagasi by IIFA have CVL, even if clinical changes are not yet apparent. It is evident that the canine population in Araguaína may be simultaneously infected with L. chagasi and T. cruzi. Therefore, a broad epidemiological assessment is necessary, especially in areas where the diseases are endemic. The Kappa coefficient showed moderate agreement between IIFA and ELISA for CVL diagnosis. The samples that diverged suggest a requirement for a combination of diagnostic methods to confirm leishmaniasis in dogs.
Conclusions
The present study demonstrated the lack of cross-reactivity betweenL. chagasi and T. cruzi by IIFA; however, cross-reactivity was detectable when using ELISA, which uses the soluble protein antigen extract from L. chagasi promastigotes. Additionally, the recognition of anti-T. cruzi antibodies suggests involvement of the dog in the epidemiology of CD in Araguaína.
